Form 8.3 - Willis Towers Watson plc - Amendment

LONDON--(BUSINESS WIRE)-- 

Ap19

FORM 8.3 - Amendment to Sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	Barclays PLC.
Company dealt in	WILLIS TOWERS WATSON PLC
Class of relevant security to which the	ORD
dealings being disclosed relate (Note 2)
Date of dealing	05 January 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:		ORD
		Long		Short
		Number	(%)	Number	(%)
(1)	Relevant securities
		2,992,177	2.32%	681,891	0.53%
(2)	Derivatives (other than options):
		354,221	0.27%	744,551	0.58%
(3)	Options and agreements to
	purchase/sell:	0	0.00%	0	0.00%
	TOTAL:
		3,346,398	2.60%	1,426,442	1.11%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit
Purchase	1	203.0000   USD
Purchase	6	205.4650   USD
Purchase	40	202.5200   USD
Purchase	63	202.1204   USD
Purchase	100	203.7500   USD
Purchase	100	201.7600   USD
Purchase	102	201.6345   USD
Purchase	200	201.7250   USD
Purchase	212	201.9148   USD
Purchase	300	202.3566   USD
Purchase	323	202.1671   USD
Purchase	330	202.0087   USD
Purchase	372	201.9307   USD
Purchase	451	201.4862   USD
Purchase	502	202.6316   USD
Purchase	553	202.6831   USD
Purchase	748	202.6405   USD
Purchase	775	202.4187   USD
Purchase	844	202.5691   USD
Purchase	876	202.0768   USD
Purchase	1,058	202.5868   USD
Purchase	1,068	202.0973   USD
Purchase	1,106	204.1922   USD
Purchase	1,240	202.3632   USD
Purchase	1,390	201.7375   USD
Purchase	4,014	202.2455   USD
Purchase	4,146	202.3905   USD
Purchase	5,385	202.3278   USD
Purchase	6,542	201.9946   USD
Purchase	8,186	202.0000   USD
Purchase	8,778	202.3806   USD
Purchase	10,776	202.0185   USD
Purchase	12,442	202.4628   USD
Purchase	17,064	202.4400   USD
Purchase	18,979	202.1423   USD
Purchase	22,992	202.6602   USD
Purchase	27,162	202.1148   USD
Sale	6	201.7700   USD
Sale	9	202.6900   USD
Sale	38	203.5400   USD
Sale	100	204.2000   USD
Sale	100	204.6200   USD
Sale	100	204.0350   USD
Sale	115	202.7869   USD
Sale	200	203.8950   USD
Sale	209	202.6746   USD
Sale	248	201.9307   USD
Sale	287	202.4334   USD
Sale	336	202.0704   USD
Sale	723	202.8030   USD
Sale	737	203.3047   USD
Sale	768	202.9215   USD
Sale	860	202.0962   USD
Sale	1,026	202.0292   USD
Sale	1,096	202.6382   USD
Sale	1,208	202.8795   USD
Sale	1,400	202.6807   USD
Sale	1,400	202.9085   USD
Sale	1,716	202.1780   USD
Sale	1,771	202.5724   USD
Sale	1,849	202.7410   USD
Sale	2,016	202.9160   USD
Sale	2,700	203.0627   USD
Sale	2,736	202.8012   USD
Sale	4,182	202.2237   USD
Sale	5,104	202.0000   USD
Sale	6,194	201.9790   USD
Sale	7,324	202.2516   USD
Sale	10,441	202.5441   USD
Sale	10,502	202.2872   USD
Sale	20,905	202.0810   USD
Sale	31,035	202.0188   USD
Sale	40,477	202.4063   USD

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD

Nature of transaction (Note 6)

Number of relevant securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?	NO
Date of disclosure:	8 Jan 2021
Contact name:	Large Holdings Regulatory Operations
Telephone number:	020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection